Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like Anti-fibrotic drug shows promise in breast cancer September 19, 2024 New drug targets key mechanism in ALS, protects motor neurons February 8, 2024 Global surge of highly pathogenic avian influenza H5N1 October 22, 2023